Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jiph.2021.05.001 | DOI Listing |
Front Microbiol
December 2024
Maximum Containment Facility, ICMR-National Institute of Virology, Pune, India.
Introduction: India has experienced seven outbreaks of the Nipah virus (NiV) since 2001, primarily occurring in the southern and eastern regions of the country. The southern region has been the main site for these outbreaks. In contrast, the eastern region, which borders Bangladesh, has not reported any outbreaks since 2007.
View Article and Find Full Text PDFJ Infect
January 2025
Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia. Electronic address:
Objective: To evaluate the long-term humoral immune response to Nipah virus (NiV) in a cohort of 25 survivors after 25 years of post-infection.
Methods: A total of 25 survivors of NiV infection from the 1998 outbreak were recruited for sample collection. The serum IgG antibody response to NiV antigens, specifically nucleocapsid (N), fusion glycoprotein (F) and attachment glycoprotein (G) was evaluated using ELISA.
Viruses
October 2024
Faculty of Biotechnology, Lomonosov Moscow University of Fine Chemical Technology, Moscow 119571, Russia.
Adv Exp Med Biol
November 2024
Department of Biochemistry, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
The chapter explores ways to increase global preparedness as well as reactions to the Nipah virus, which is a devastating zoonotic risk with serious health impacts. The Nipah virus is transmitted through bats and humans and poses major problems due to its high mortality rate, fast spread, and the absence of treatments or vaccines. The chapter argues for a holistic strategy incorporating the One Health framework to address human, animal, and environmental health interdependence.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!